Abstract: Bananas are one of the top ten world food crops. Unlike most other major food crops, bananas are difficult to genetically improve. The challenge is that nearly all banana cultivars and landraces are triploids, with high levels of male and female infertility. There are a number of international conventional breeding programs and many of these are developing new cultivars. However, it is virtually impossible to backcross bananas, thus excluding the possibility of introgressing new traits into a current cultivar. The alternative strategy is to "modify" the cultivar itself. We have been developing the capacity to modify Cavendish bananas and other cultivars for both disease resistance and enhanced fruit quality. Initially, we were using transgenes; genes that were derived from species outside of the Musa or banana genus. However, we have recently incorporated two banana genes (cisgenes) into Cavendish; one to enhance the level of pro-vitamin A and the other to increase the resistance to Panama disease. Modified Cavendish with these cisgenes have been employed in a field trial. Almost certainly, the next advance will be to edit the Cavendish genome, to generate the desired traits. As these banana cultivars are essentially sterile, transgene flow and the outcrossing of modified genes into wild Musa species. are highly unlikely and virtually impossible in other triploid cultivars. Therefore, genetic changes in bananas may be compatible with organic farming.
Bananas are a fascinating crop. They are grown almost exclusively in the wet tropics and sub-tropics, but are consumed in nearly every country, as the world's most popular fruit. However, they are much more than that. Unlike the other nine of the world's top 10 food crops, bananas are eaten both raw and cooked, depending on the cultivar. About 60% of bananas are eaten raw, as a dessert fruit, and the other 40% are cooked during processes steaming, boiling, roasting, and frying. These cooked bananas include the East African Highland bananas and the African and Pacific plantains, and are extremely important starch sources in Africa and Asia. In some countries, such as Uganda, cooking bananas are the staple food, where consumption levels are in excess of 500 g per person per day. More than 120 million tonnes of banana fruit are produced each year, with the three biggest producers, India, Uganda, and China, consuming almost all of what they produce domestically [1] . About 85% of worldwide banana production is consumed in-country. This domestic production and consumption is made up of many different cultivars; for dessert bananas, Cavendish is very common in many countries, but there are also popular local dessert cultivars, such as Lakatan in the Philippines, Rasthali in India, Gros Michel and Sukali Ndizi in Uganda, and Prata in Brazil. In contrast, the 15% of export bananas, those consumed in developed countries, is almost exclusively one dessert cultivar, Cavendish. The large exporting countries are primarily in Latin America and include Ecuador,
The Challenges and Opportunities for Future Genetic Improvement
The challenges: Diseases are the major constraint to banana production worldwide. While the Panama disease (Fusarium wilt) epidemic in Gros Michel was the first major banana calamity, it is certainly not the last. Currently, there are four major diseases causing very serious concerns and losses: Fusarium wilt tropical race 4 (TR4), black Sigatoka, banana bunchy top disease, and banana Xanthomonas wilt (BXW). There are also larger number of diseases and pests of lesser importance, including yellow Sigatoka, freckle, banana bract mosaic, banana streak, Moko, blood disease, nematodes, and weevils [9] .
The most serious threat is Fusarium wilt TR4 [8, 10] ( Figure 1A -C). TR4 differs from the disease that decimated Gros Michel last century, in that it infects and kills Cavendish, as well as a number of other race 1 resistant cultivars. As such, TR4 has the capacity to kill more than 50% of the bananas grown in the world today. The disease is similar to race 1, in that it is soil-borne, there are no chemical controls, and once the soil becomes infested the fungus can survive for decades [11, 12] . It is spread by infected plants, soil on boots, clothing, machinery, and in water, including irrigation and flood water.
Believed to have originated in Indonesia [13] , it is now widespread in south-east Asia, including China, Taiwan, and the Philippines [8] , where it is threatening both the Cavendish export industry and the local Lakatan production [14] . It is also present in northern Australia [8, 15] . Additionally, this disease is on the move. It has recently been recorded in Pakistan near the Indian border [16] , Lebanon [17] and Jordan in the Middle East [18] , and Mozambique in Africa [19] . Some tolerant, but not resistant, selections from Cavendish have been reported [20] .
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Bunchy top ( Figure 1D ), caused by Banana bunchy top virus (BBTV), is widespread in Asia and Africa, but not present in the Americas [22, 23] . Spread by aphids and via infected planting material, the disease is aggressively moving through Africa, recently destroying the smallholder-based Cavendish industry in Malawi and becoming established in Nigerian plantains [24] [25] [26] . Importantly, the disease can be controlled, but cannot be eradicated in well organised commercial settings through the use of virus-free planting material and the regular plantation inspection and eradication of infected plants. These schemes are rarely implementable in smallholder and subsistence farming environments.
Banana Xanthomonas wilt (BXW), caused by the bacterium Xanthomonas campestris pv. musacearum, has been responsible for major losses in the past decade in East Africa, after apparently moving from Ethiopia to Uganda, Rwanda, Burundi, Democratic Republic of Congo, Tanzania, and Kenya [25] . The bacterium is transmitted through the soil, insects, and on contaminated implements [27] . Control is effective through the sterilisation of work tools, destruction of infected plants, and fallow of contaminated land. However, maintaining the necessary level of disease management in smallholder and subsistence farming environments is proving to be challenging.
For these four diseases, genetic resistance is the most appropriate control strategy.
Other opportunities: The potential for the genetic improvement of bananas is not limited to disease resistance. Improving the nutritional value of bananas has become a prime target, particularly where cooked bananas are consumed as one of the dietary staples. In most developing countries, the "poorest of the poor" are becoming increasingly dependent on one or a few high starch staples, including rice, maize, cassava, wheat, sorghum, and bananas. Invariably, these staples are low in essential micronutrients, such as pro-vitamin A and iron. The levels of vitamin A deficiency (VAD) and iron deficiency anaemia (IDA) in most developing countries are unacceptably high. For instance, Black Sigatoka, caused by the air-borne fungus Mycosphaerella fijiensis (Morelet), severely affects bananas in most producing countries [21] . It can be controlled by the application of fungicides, but often requires spraying more than once a week. This may cause serious long term environmental damage. Spraying is usually limited to commercial production operations, where the cost of control can be a third of the production costs. Smallholder and subsistence farmers rarely have access to these fungicides and must accept the production losses, and with it, the loss of food and income.
Other opportunities: The potential for the genetic improvement of bananas is not limited to disease resistance. Improving the nutritional value of bananas has become a prime target, particularly where cooked bananas are consumed as one of the dietary staples. In most developing countries, the "poorest of the poor" are becoming increasingly dependent on one or a few high starch staples, including rice, maize, cassava, wheat, sorghum, and bananas. Invariably, these staples are low in essential micronutrients, such as pro-vitamin A and iron. The levels of vitamin A deficiency (VAD) and iron deficiency anaemia (IDA) in most developing countries are unacceptably high. For instance, in Uganda, where bananas are the staple food, vitamin A deficiency is between 15% and 30% in children under 60 months, and about the same for women of a child-bearing age [28, 29] . The levels of IDA are worse and are persisting in Uganda and other African countries, despite strategies of food fortification and supplements being successfully implemented in other parts of the world. Biofortification, the process of increasing the levels of essential nutrients in particularly staple foods, is now being developed as an additional strategy to tackle these micronutrient deficiencies, and in a way, this does not require continual external inputs [30] [31] [32] . The most advanced of the biofortification by genetic modification (GM) projects is Golden Rice (http://www.goldenrice.org/). This program, as well as BioCassavaPlus (https://www.danforthcenter.org/scientists-research/research-institutes/institutefor-international-crop-improvement/crop-improvement-projects/biocassava-plus) and Banana21 (http://www.banana21.org/), were funded by the Bill & Melinda Gates Foundation as part of the Grand Challenges in Global Health initiative.
There are additional opportunities, such as: increasing fruit shelf life [33] ; increasing abiotic stress tolerance, including drought tolerance [34] ; and enhancing bananas as a functional food, for instance by producing banana fruit with increased levels of vitamin C [35] , which is likely to increase iron bioavailability.
Conventional Breeding or Genetic Modification
Despite cultivated bananas having low levels of male and female fertility, it is possible to breed bananas using conventional techniques. There are a number of internationally established breeding programs, usually with an emphasis on different banana types (dessert or cooking) and traits. The FHIA program in Honduras (http://www.fhia.org.hn/) has been in operation for many decades and has released a number of hybrids; some of which have important disease resistances, such as black Sigatoka resistance and Fusarium wilt resistance. The EMBRAPA (Brazil, https://www.embrapa.br/) and CIRAD (Guadeloupe, http://www.cirad.fr/en) programs are also concentrating on generating new hybrids with disease resistances. The IITA (Nigeria and Tanzania, http://www.iita.org/) and the NARO (Uganda, http://www.naro.go.ug/) programs also target disease resistance and concentrate on developing new cooking banana and plantain cultivars.
The conventional banana breeding programs depend on utilising fertile diploids to hybridise either triploid cultivars or tetraploid intermediates. This has been a successful strategy. However, it has two limitations. The first is that, because of the low male and female fertility, it is virtually impossible to repeatedly backcross the initial hybrid to the original cultivar and therefore, introgressing new traits into the accepted cultivars is also virtually impossible. The second limitation is that not all of the major desirable traits are available in the fertile diploids and thus, these traits cannot be included in conventional breeding programs. For instance, fertile diploids with resistance to black Sigatoka and/or Fusarium wilt race 1 and TR4 are available and have been exploited very effectively [36] [37] [38] [39] [40] . However, fertile diploids with resistance to banana bunchy top or banana Xanthomonas wilt, have not been identified.
A third and unexpected limitation of conventional banana breeding relates to one of the major progenitors of cultivated bananas, Musa balbisiana. This species contributes disease resistance and abiotic stress tolerance. At least one copy of its genome is present in many of the major cultivated bananas, including the plantains, the cooking bananas Saba and Bluggoe, and most of the locally popular acid sweet dessert bananas. The genome of M. balbisiana, however, contains integrated sequences of the pararetrovirus Banana streak virus (BSV), which upon hybridisation, can recombine to form infectious BSV and symptoms of that infection [41] . This discovery has limited the use of parents containing a M. balbisiana genome, thereby severely reducing the available banana breeders' gene pool.
In contrast, GM can be applied to add a single gene or a few genes to an already highly desirable cultivar. This is extremely important in bananas. As previously noted, Cavendish accounts for more than 40% of the world's banana production. It is so amazingly popular because, for producers, it is high yielding and has excellent transportability and, for the consumer, it has a highly desirable texture and flavour. It excels as a cultivar for providing "cheap fruit" to the world market. No other known selection or conventionally bred cultivar has this combination of characteristics; there is no known replacement for Cavendish. Unfortunately, Cavendish is susceptible to black Sigatoka, banana bunchy top, banana Xanthomonas wilt, and Fusarium wilt TR4 [19] [20] [21] [22] . A further example is the East African Highland bananas, which are grown extensively in Uganda, Rwanda, and the Democratic Republic of Congo, as well as Kenya and Tanzania. These cooking bananas probably account for more than 10% of the world's production [42] . More than a staple food, these bananas are an integral part of the culture, particularly in Uganda. The flavour, texture, and "processability" are paramount, and not easily replicated in new cultivars. Unfortunately, these bananas are susceptible to black Sigatoka, banana bunchy top, and banana Xanthomonas wilt. There are many other examples: Lakatan in the Philippines is the dessert banana of choice in a country that produces 15% of the exported Cavendish bananas. Lakatan is susceptible to Fusarium wilt TR4 and banana bunchy top [43] .
The accessible gene pool available for GM is significantly broader than that available to conventional banana breeders and, as a result, genes for resistance to BBTV and BXW have already been identified [44] [45] [46] [47] . Further, genes from M. balbisiana are available for use in genetic modification, as there is no possibility of transferring BSV genes [48] .
Similar to conventional breeding with the fertile diploids as a source of desired traits, GM of bananas depends on transformable tissue and genes for the target trait. The transformable tissue of choice for bananas is embryogenic cell suspensions derived from immature male flowers [49] . While the development of these cell suspensions is a lengthy process (Figure 2) , it is probable that, with sufficient effort, it should be possible to generate them from most cultivars. In our laboratory, we have generated transformable cell suspensions from Cavendish, Gros Michel, Lady finger, and Goldfinger. Other cultivars from laboratories include the East African Highland banana, Gonja (plantain), and Rasthali. Additionally, efficient transformation protocols are available for bananas, for both Agrobacterium-mediated transformation and microprojectile bombardment [49] [50] [51] . There are a number of laboratories around the world that have established banana transformation pipelines, including ours at Queensland University of Technology (https://www.qut.edu.au/), the IITA in Kenya (http://newint.iita.org/), NARO in Uganda (http://www.naro.go.ug/), the Bhabha Atomic Research Centre in India (http://www.barc.gov.in/), and the Catholic University of Leuven in Belgium (https://www.kuleuven.be/english).
Very importantly, genes that can be mobilised into genetically modified bananas are becoming increasingly available, and it is likely that the availability of suitable genes will grow significantly. There are, and will be, two major sources: banana genes and genes from other sources, particularly from other plant species or genes that trigger natural mechanisms in bananas, as well as other plant species. There is, of course, the potential to mobilise bacterial genes for traits such as herbicide tolerance and insect resistance, but this certainly has not been a priority for bananas. The first banana genome sequence was published in 2012 [52] ; this sequence is of a double haploid M. acuminata ssp. malaccensis and has immediately become a major resource. Genes for the resistance to Fusarium wilt TR4 and black Sigatoka exist in M. acuminata ssp. malaccensis. The genome sequence of M. balbisiana have also been published [53] , as well as numerous transcriptomic data from various banana tissues [54] [55] [56] . In parallel, there are mapping programs to identify loci for various traits, such as resistance to Fusarium wilt TR4. Coupled with the genome sequences, these programs should result in the definitive identification of the gene or genes responsible for specific traits. Further, new "generic" technologies are being developed or refined, and can be applied to the GM of bananas. These include RNA interference technologies, an understanding of the different resistance and other metabolic pathways in plants, and gene editing technologies such as CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated proteins) [57, 58] . 
The Progress with Genetically Modified Bananas
There has been a dramatic increase in the number of published reports of genetically modified bananas over the past five years, with a multitude of different genes targeting different traits. The majority of these studies have been reports from a glasshouse evaluation and therefore, it is difficult to determine whether they only represent experimental projects, or whether they are part of a program to progress to field trial, and ultimately, to general release. The most targeted traits have been pest and disease resistance, abiotic stress tolerance, and fruit ripening, and these have included resistance to BBTV using RNAi (RNA interference) [44, 59] , resistance to Fusarium wilt race 1 using antiapoptosis genes [60] , RNAi [61] or a defensin gene [62] , resistance to nematodes using plant-derived or synthetic peptides [63] , and the over-expression of a banana-derived WRKY transcription factor to alter abiotic responses [64] . These reports, in addition to a number of others, have used a range of banana genes, RNAi constructs derived from banana pathogens, or genes not derived from bananas.
Of greater interest are the genetically modified bananas that have progressed through to field trials. There were at least two early field trials which both assessed black Sigatoka resistance, but neither of these appear to have progressed further than the initial trial. The first of the more recent field trials commenced in 2009 in Australia, as part of a Bill & Melinda Gates Foundation funded Grand Challenges in Global Health project, to develop cooking bananas for Uganda with enhanced levels of pro-vitamin A (PVA) and iron [31] . As previously stated, VAD and IDA remain major public health problems in East Africa, despite the widespread intervention of supplements and food fortification. The biofortification approach aims to generate East African Highland bananas, the staple food of Uganda, with high levels of PVA. The project is a collaboration between Queensland University of Technology in Australia and the National Agricultural Research Organisation of Uganda. The initial Australian field trial was in Cavendish ( Figure 3A) to identify a strategy that could be transferred to Uganda, to transform into the Ugandan cultivars. From this and successive Australian field trials, two promoters were identified, together with one transgene, that provided enhanced levels of PVA ( Figure 3B ) nearly three-fold over target, with a stable expression over more than five years. These gene constructs have been transferred to Uganda and have been transformed 
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There exists the potential to combine both enhanced PVA and BXW resistance in the one genetically modified line for East African Highland bananas in Uganda. This would be very attractive, as it combines two field-proven GM strategies, with one targeting resistance to a major disease constraint and the other targeting a major micronutrient deficiency.
In January, 2012, we planted a field trial in northern Australia to test the resistance to Fusarium wilt TR4 in Cavendish genetically modified with either an anti-apoptosis gene, Ced9 [60] , or a nucleotide binding site-leucine rich repeat (NBS-LRR) type resistance (R) gene isolated from a resistant seedling of Musa acuminata ssp. malaccensis [66, 67] , in an area that had been devastated by TR4. The trial ran for three years and the outcomes will be published shortly. Very recently, results from a field trial of Cavendish bananas with delayed fruit ripening were reported [33] . These researchers had down-regulated the expression of a banana MADS box gene homologous to the tomato ripening inhibitor (RIN)-MADS ripening gene using RNAi, and demonstrated both ripening delay and extended shelf life. Finally, we have generated a large number of Cavendish lines with a range of RNAi constructs targeting different BBTV genes, that have shown levels of BBTV resistance in the glasshouse in Australia [59] . Many of these lines have been progressed through to a field trial recently planted in Malawi. The RNAi constructs specifically target the South Pacific strain of BBTV, which is the only strain reported from Africa [26] .
Banana GM and Organic Farming
Many of the principles of organic farming overlap with the primary principles of the major banana biotechnology programs: elimination of pesticides and the sustainable production of traditional and "heirloom" cultivars and landraces, in the case of biotechnology, through the genetic improvement of these cultivars and landraces. Bananas are very different to the broadacre genetically modified commodity crops such as soybeans, maize, cotton, and canola. Only 15% of banana production is exported. This production is based almost exclusively on Cavendish, and is primarily monoculture plantation production with high levels of pesticide usage to control nematodes and fungal diseases. In contrast, the majority of the other 85% of bananas are produced by small holder and subsistence farmers in developing countries and most of these bananas are consumed locally, either on the farm or within a few kilometres. It is likely that a very significant proportion of these bananas are grown without inorganic fertilisers and without the application of pesticides or herbicides. Thus, many bananas grown and consumed in the tropics and sub-tropics are, by circumstance, "organic". It is not that these bananas are unaffected by pests and diseases; they are. Depending on the geographical location, these include weevils, black and yellow Sigatoka, Fusarium wilt race 1 and TR4, BBTV, and bacterial wilts such as Blood disease, Moko, and BXW. The resources required to control these biotic stresses are invariably unavailable to the small holder farmers and subsequent losses are inevitable and endured. The potential of GM is to provide resistance to these pests and diseases in the cultivars and landraces that are traditionally produced by these farmers. Under current definitions, these genetically modifiedimproved cultivars with disease resistance would no longer be considered as organic, but their production would be significantly more sustainable.
Importantly, while about 25% of the non-export bananas are the dominant Cavendish cultivar, the remaining 75% consist of a wide range of diverse cultivars and landraces, which are highly valued locally. These cultivars and landraces are under as much threat as Cavendish, but receive little international publicity; it is the threat of an end to cheap banana fruit to markets in North America, Europe, and Japan, that receives the most attention. Although developing a disease-resistant Cavendish or Cavendish replacement is extremely important for both the export trade and local production, just as important is conserving the wonderful diversity seen in local markets throughout the wet tropics and subtropics. As a consequence of the very low fertility of most triploid cultivated bananas, it is essentially impossible to introgress new traits into these cultivars via multiple backcrosses. At present, the genetic improvement, and thus the long term sustainable production of these cultivars, can only be achieved through genetic modification.
The conventional breeding programs are targeting the development of new cultivars with resistance to two of the major diseases, black Sigatoka and Fusarium wilt TR4, as these traits are available to banana breeders within the banana gene pool. The GM programs are targeting the development of resistance to Fusarium wilt TR4, BBTV, and BXW in current cultivars and landraces, with either banana genes, other plant genes, or by triggering natural banana virus resistance mechanisms. No suitable GM approach for black Sigatoka resistance has been identified, but it will come. Clearly, there is an opportunity to incorporate both conventional and GM approaches to optimise new cultivars, but this also is yet to be achieved. Interestingly, the current control regimes for all four of the major diseases of bananas, comprised of black Sigatoka, BXW, banana bunchy top, and Fusarium wilt TR4, involve the use of chemicals. The large scale use of fungicides to control black Sigatoka is well documented [68] . One major element of the current control of Fusarium wilt TR4 is the use of disinfectants for boots and vehicles. Elements for the control of banana bunchy top include herbicides to kill infected plants and insecticides to kill the aphid vectors, while disinfectants are used to sterilise tools for BXW control and herbicides are used to kill infected plants. Genetic resistance to these diseases would dramatically reduce the use of harsh chemicals in control regimes.
The genome revolution is well under way and bananas are not being left behind. Genes for pest and disease resistances will become available at an ever increasing pace, and the majority of these will come from bananas themselves, drawing on the amazing genetic diversity of both wild and cultivated bananas. Banana genes have already successfully been mobilised using GM for the development of bananas with elevated pro-vitamin A and delayed fruit ripening.
In parallel, new genetic technologies are being developed and are already being adapted to bananas. CRISPR-Cas9 is the first of probably many genome-editing technologies, and groups such as ours are already developing this approach for the next generation of genetically improved bananas. The line between conventionally bred and genetically modified is becoming increasingly blurred, and this will continue. It is likely that smaller labs in the wet tropics and subtropics will develop the capacity to genetically but non-conventionally improve bananas, and it is likely that they will ultimately concentrate on improving their local favourites.
The future of genetically improved bananas looks very positive, if it is allowed to develop unimpeded: this includes the conservation of traditional and heirloom cultivars and landraces, the elimination of pesticides, and a reduction of the impact of micronutrient deficiencies in developing countries, without the risk of transgene escape from modified bananas to other cultivars or to wild-type plants. Moreover, it is likely that these bananas will be developed with the strong input and influence of local organisations. The genetic resources will be broadly held. Bananas are an excellent example where the likely outcomes of the application of GM match with many of the desired outcomes of organic production.
